Rigimmune
Farmington, US · 1 known investors
RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.
Founders & leadership
AM
Anna Marie PyleCo-founder
AI
Akiko IwasakiCo-founder
Investors · 1
Competitors · 3
by search overlap
VerImmune10 shared keywordsVerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.
Inimmune7 shared keywordsInimmune is a clinical-stage biotech company that discovers and develops immunotherapies based on innate immune modulation, including Toll-like receptor agonists, to treat inflammatory conditions such as allergy, cancer, and autoimmune disease. Its lead program, INI-2004, is an intranasal TLR4 agonist in Phase 2 trials for allergic rhinitis, alongside INI-4001, a TLR7/8 agonist in Phase 1 oncology trials, plus pre-clinical vaccine adjuvant work.
BellBrook Labs7 shared keywordsBellBrook Labs supplies life-science research products and services to laboratories, distributed internationally through regional partners across Europe, Asia, and Oceania. Its offerings serve the biotechnology and drug-discovery research market.
Companies competing with Rigimmune for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Rigimmune do?
- RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.
- Who founded Rigimmune?
- Rigimmune was founded by Anna Marie Pyle, Akiko Iwasaki.
- Who are Rigimmune's investors?
- Rigimmune's investors include F-Prime Capital.
- Where is Rigimmune headquartered?
- Rigimmune is headquartered in Farmington, US.